Maria Adrielle Vicente

Dr. Maria Adrielle Vicente


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
BMBruno Lemes Marques
Bruno Lemes Marques
PLPedro Henrique Cassaro Lirio
Pedro Henrique Cassaro Lirio
MVMaria Adrielle Vicente
Maria Adrielle Vicente
PUPaula Unzueta-Larrinaga
Paula Unzueta-Larrinaga
LULeyre Urigüen
Leyre Urigüen
Alline CamposAlline Campos
Alline Campos
Background and Objectives: Neuropsychiatric disorders pose a major global health challenge, marked by high prevalence, limited diagnostic precision, and suboptimal therapeutic outcomes. Current diagnoses remain primarily clinical, lacking objective biomarkers, while many patients experience poor remission rates and frequent relapse. The endocannabinoid system (ECS), a central regulator of synaptic plasticity, neuroinflammation, and stress responses, is increasingly implicated in depression, anxiety, schizophrenia, and neurodegenerative diseases. In parallel, extracellular vesicles (EVs) have emerged as critical mediators of intercellular communication and promising biomarker sources, as they reflect the physiological or pathological status of their cells of origin. This review examines the hypothesis that interactions between ECS signaling and EV-mediated communication form a convergent pathway shaping vulnerability and resilience in neuropsychiatric disorders, with potential implications for biomarker identification and therapeutic innovation. Methods: This hypothesis-driven review was developed using a narrative approach, focusing on the interface between cannabinoids and EVs in neuropsychiatric conditions. Relevant publications were identified through PubMed, Scopus, and Web of Science searches up to September 2025. Results: Emerging evidence indicates a bidirectional relationship between ECS activity and EV biology: endocannabinoids can be loaded into EVs to facilitate intercellular signaling, while phytocannabinoids such as THC and CBD can alter EV release and cargo composition. Conclusions: We propose a hypothesis-driven framework in which the possible interplay between cannabinoids and EVs may stimulate new research and support the development of biomarker-guided, personalized therapeutic strategies for neuropsychiatric disorders.

4 March 2026 in Neuropharmacology
Verified
Journal Article
Closed access
FSFrancieleF. Scarante
FrancieleF. Scarante
VLVinícius D. Lopes
Vinícius D. Lopes
EFEduardo J. Fusse
Eduardo J. Fusse
MVMaria Adrielle Vicente
Maria Adrielle Vicente
GAGabriel H.D. de Abreu
Gabriel H.D. de Abreu
Alline CamposAlline Campos
Alline Campos